Screening for diabetes and cardiovascular risk does not decrease mortality

25 Aug 2017


Three trials, published in Diabetologia, show that screening for type 2 diabetes and cardiovascular risk in the general population may not reduce mortality and cardiovascular disease. However, for individuals already diagnosed with diabetes, screening is associated with a reduction in mortality.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story